Effectiveness of probiotics in irritable bowel syndrome: methodological quality of meta-analyses and systematic reviews
By:
References
- Wilkins T, Pepitone C, Alex B, Schade RR. Diagnosis and management of IBS in adults. Am Fam Physician. 2012;86:419-426.22963061
- Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56:1770-1798.10.1136/gut.2007.11944617488783
- Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. J Manag Care Pharm. 2004;10:299-309.15298528
- Dupont HL. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther. 2014;39:1033-1042.10.1111/apt.1272824665829
- Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol. 2015;12:36-49.10.1038/nrgastro.2014.20025446728
- Hyland NP, Quigley EM, Brint E. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions. World J Gastroenterol. 2014;20:8859-8866.25083059
- Hussain Z, Quigley EM. Systematic review: complementary and alternative medicine in the irritable bowel syndrome. Aliment Pharmacol Ther. 2006;23:465-471.1644146610.1111/j.1365-2036.2006.02776.x
- Jarcho JM, Chang L, Berman M, et al. Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study. Aliment Pharmacol Ther. 2008;28:344-352.1908633210.1111/j.1365-2036.2008.03721.x
- Böhn L, Störsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015;149:1399-1407. e2.2625504310.1053/j.gastro.2015.07.054
- Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22-32.10.1056/NEJMoa100440921208106
- Pineiro M, Stanton C. Probiotic bacteria: legislative framework - requirements to evidence basis. J Nutr. 2007;137(3 suppl 2):850S-853S.1731198610.1093/jn/137.3.850S
- Dai C, Zheng CQ, Jiang M, Ma XY, Jiang LJ. Probiotics and irritable bowel syndrome. World J Gastroenterol. 2013;19:5973-5980.2410639710.3748/wjg.v19.i36.5973
- Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.10.1186/1471-2288-7-1017302989
- Corbitt M, Campagnolo N, Staines D, Marshall-Gradisnik S. A systematic review of probiotic interventions for gastrointestinal symptoms and irritable bowel syndrome in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Probiotics Antimicrob Proteins. 2018;10:466-477.2946450110.1007/s12602-018-9397-8
- Ortiz-Lucas M, Tobías A, Saz P, Sebastián JJ. Effect of probiotic species on irritable bowel syndrome symptoms: a bring up to date meta-analysis. Rev Esp Enferm Dig. 2013;105:19-36.2354800710.4321/S1130-01082013000100005
- Didari T, Mozafari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J Gastroenterol. 2015;21:3072-3084.10.3748/wjg.v21.i10.307225780308
- Zhang Y, Li L, Guo C, et al. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol. 2016;16:62.2729625410.1186/s12876-016-0470-z
- Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Curr Med Res Opin. 2017;33:1191-1197.10.1080/03007995.2017.129223028166427
- Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1547-1561; quiz 1546, 1562.10.1038/ajg.2014.20225070051
- Tiequn B, Guanqun C, Shuo Z. Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: a meta-analysis. Intern Med. 2015;54:243-249.10.2169/internalmedicine.54.271025748731
- Li DQ. Meta-analysis and evaluation of clinical effects of probiotics on irritable bowel syndrome (IBS). J Pract Diagnosis Ther. 2016;27:4531-4533 (in Chinese).
- Zhao ZF, Yang T, Yao P. Meta-analysis of the efficacy of probiotics in the treatment of irritable bowel syndrome. Chin J New Drugs Clin Remed. 2014;33:26-35 (in Chinese).
- Shu XC, Zhou SP, Chen CY, Wang SD, Wang FY. A systematic evaluation of the randomized controlled trial of irritable bowel syndrome with probiotics. Chin J Evidence-Based Med. 2012;12:840-847 (in Chinese).
- Yao L, Fu L, Zhao SJ. Meta-analysis of the clinical efficacy of probiotics in the treatment of irritable bowel syndrome in China. Chin J Evidence-Based Med. 2012;12:602-607.
- Hu Y, Tao L, Lyu B. A meta-analysis of probiotics for the treatment of irritable bowel syndrome. Chin J Internal Med. 2015;54:445-451.
- Lan Y, Luo HS. A meta-analysis of probiotics in the treatment of irritable bowel syndrome. J Gastroenterol Hepatol. 2011;20:809-813.
- Salem AE, Singh R, Ayoub YK, Khairy AM, Mullin GE. The gut microbiome and irritable bowel syndrome: state of art review. Arab J Gastroenterol. 2018;19:136-141.10.1016/j.ajg.2018.02.00829935865
- Ferguson LR, Laing B, Marlow G, Bishop K. The role of vitamin D in reducing gastrointestinal disease risk and assessment of individual dietary intake needs: focus on genetic and genomic technologies. Mol Nutr Food Res. 2016;60:119-133.2625117710.1002/mnfr.201500243
- Martínez C, González-Castro A, Vicario M, Santos J. Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome. Gut Liver. 2012;6:305-315.2284455710.5009/gnl.2012.6.3.305
- Major G, Spiller R. Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes. 2014;21:15-21.2429646210.1097/MED.0000000000000032
- Jiang T, Savaiano DA. Modification of colonic fermentation by bifidobacteria and pH in vitro. Impact on lactose metabolism, short-chain fatty acid, and lactate production. Dig Dis Sci. 1997;42:2370-2377.
Language: English
Page range: 115 - 121
Published on: Jul 10, 2019
Published by: Shanxi Medical Periodical Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2019 Yuan Jia, Li-Min Guo, Si-Yuan Yang, Qian Wu, Fan-Jie Meng, published by Shanxi Medical Periodical Press
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.